group A streptococcus


Also found in: Dictionary, Thesaurus.
Related to group A streptococcus: Group B streptococcus

group A streptococcus

Infectious disease A group of bacteria that are normally skin and saprobes of the skin and oral cavity; when pathogenic, GAS spreads by direct person-to-person contact Conditions Strep throat, impetigo, scarlet fever, rheumatic fever, postpartum fever, wound infections, pneumonia; invasive GAS cause necrotizing fasciitis, toxic shock syndrome
References in periodicals archive ?
It is conceivable that a growing number of patients with STSS have been infected with bacteria other than group A streptococcus," Ken Kikuchi, a professor of infectious diseases at Tokyo Women's Medical University said.
The majority are group A streptococcus pharyngitis, more commonly known as strep throat, but group A strep also is the major cause of preventable childhood heart disease caused by rheumatic fever.
More importantly, resistance to other antibiotics such as Macrolides is on the increase, which can be monitored only by regular testing of Group A Streptococcus strains to such antibiotics.
Similarly, surgical site infections with Group A Streptococcus spp.
Group A streptococcus is responsible for common infections of the throat ("strep throat') and skin.
As outpatient prescriptions of erythromycin dried up between 1991 and 1996, the resistance rate among group A streptococcus bacteria isolated from throat swabs, pus, and blood samples fell from 16.
7] Although Schrock states that the strains of group A streptococcus used in his study were "stored at -70 [degrees] for group A serotyping," no further data about the specimens are given.
The report includes a compilation of currently active projects in development of vaccines targeting pneumococcus (Streptococcus pneumoniae), Group A Streptococcus (GAS) or Group B Streptococcus (GBS) for prophylaxis of streptococcal infections.
The most common symptoms of group A Streptococcus infection include fever, pharyngitis and tonsillitis.
Diagnostic testing company Quidel Corporation (NASDAQ:QDEL) reported on Thursday the receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its Sofia Strep A fluorescent immunoassay (FIA) for use on the Sofia Analyzer for the rapid, objective detection of infections by Group A Streptococcus bacteria.
High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks.
Group A streptococcus infections cause 15%-30% of sore throats.
Full browser ?